๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials in this register

19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Clinical Study of [225Ac]Ac-FAPI-XT(XT117) Injection in Patients With Advanced Solid Tumors
NCT07135128Advanced Solid Tumor
Xiaorong Sun
Phase 1
20
Jinan
2024-10-14
Not yet open
LED Therapy for Third Molar Surgery
NCT06640439Molar, Third, Photobiomodulation, Photobiomodulation Therapy, Third Molar Surgery
Huashan Hospital
Phase EARLY_PHASE1
50
Shanghai
2024-10-14
Recruiting
Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer
NCT06547736Pancreatic Cancer
Fudan University
Phase 2
160
Shanghai
2024-10-14
Recruiting
A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer
NCT07135102Metastatic Castration-Resistant Prostate Cancer Patients
Xiaorong Sun
Phase 1
40
Jinan
2024-10-14
Recruiting
LIVERAGEโ„ข: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
NCT06632444Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Boehringer Ingelheim
Phase 3
1,800
Beijing, Changchun, Changsha, Changzhou Shi, Chengdu, Chongqing, Foshan, Fuzhou
2024-10-14
Recruiting
A Phase Ib Study of GC101 in NSCLC
NCT06473961Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer
Shanghai Juncell Therapeutics
Phase 1
20
Shanghai
2024-10-14
Active, closed
Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
NCT06622590Influenza, Human, Influenza a, Influenza Type B, Influenza Viral Infections
Institute of Medical Biology, Chinese Academy of Medical Sciences
Phase 1
180
Nanning
2024-10-13
Recruiting
Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin
NCT06698965Lung Cancer, Small Cell
Shanghai Chest Hospital
Phase 2
52
Shanghai
2024-10-13
Recruiting
Model-informed Individualized Treatment of Anti-infective Drugs
NCT06711562Osteoarticular Infections
Shandong University
Observational
300
Jinan
2024-10-12
Recruiting
Fecal Microbiota Transplantation (FMT) in Patients With Moderate to Severe Acute Pancreatitis
NCT07153809Acute Pancreatitis, Severe Acute Pancreatitis
Changhai Hospital
Not applicable
80
Shanghai
2024-10-12
Recruiting
Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections
NCT06711575Infectious Diseases of Spine
Shandong University
Observational
300
Jinan
2024-10-12
Recruiting
Efficacy of Lactobacillus Paracasei LC19 on Type 2 Diabetes
NCT06639425Type 2 Diabetes
Beijing Chao Yang Hospital
Not applicable
60
Beijing
2024-10-12
Recruiting
Profile and Regulatory Network of Exercise in Improving Metabolic Phenotypes of Patients With Prediabetes
NCT06633575Prediabetes
Shanghai Zhongshan Hospital
Not applicable
40
Shanghai
2024-10-12
Recruiting
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
NCT06418659Advanced Hepatocellular Carcinoma
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
37
Shanghai
2024-10-12
Active, closed
A Clinical Trial of TQB2102 for Injection in the Treatment of HER2 Low-Expressing Recurrent/Metastatic Breast Cancer
NCT06561607Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
542
Bengbu, Hefei, Beijing, Quanzhou, Zhangzhou, Lanzhou, Wuwei, Guangzhou
2024-10-11
Recruiting
MRI Performance and Risk Factors in Bilateral Vestibular Hypofunction
NCT07709143Bilateral Vestibular Hypofunction, Bilateral Vestibulopathy, Presbyvestibulopathy
Shanghai 6th People's Hospital
Observational
120
Shanghai
2024-10-11
Recruiting
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
NCT06581432Solid Tumours
Boehringer Ingelheim
Phase 2
588
Beijing, Changsha, Hangzhou, Hefei, Nanchang, Nanjing, Shanghai, Wuhan
2024-10-11
Active, closed
Immune Cell Subsets in SLE Patients Treated with Telitacicept
NCT06677801Systemic Lupus Erythematosus (SLE)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
50
Hangzhou
2024-10-11
Recruiting
Clinical Study of Perioperative Sleep Disorders in Cardiac Surgery
NCT06778811Sleep Wake Disorders, Esketamine and the Quality of Recovery, Dexmedetomidine
Nanjing First Hospital, Nanjing Medical University
Phase 4
180
Nanjing
2024-10-11
Not yet open
Mechanisms of Mindfulness Intervention: Cognitive Flexibility Dose Manipulation
NCT06622122Emotional Distress
Peking University
Not applicable
300
Beijing
2024-10-11
Active, closed
The Impact of Low-Dose Esketamine Combined With Ciprofol on the Quality of Early Postoperative Recovery Among Elderly Patients Undergoing Painless Gastroscopy
NCT06617039Quality of Postoperative Recovery
Northern Jiangsu People's Hospital
Not applicable
376
Yangzhou
2024-10-10
Recruiting
Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma
NCT06348264Salivary Gland Neoplasm Duct
Peking University First Hospital
Phase 2
37
Beijing
2024-10-10
Active, closed
CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
NCT06667050Gastric Adenocarcinoma
West China Hospital
Phase 2
58
Chengdu
2024-10-10
Active, closed
The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)
NCT06656962Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)
Renmin Hospital of Wuhan University
Phase 1/2
15
Wuhan
2024-10-10
Recruiting
Investigation of Cardiac Function Following Low-Intensity Ultrasound Intervention
NCT06567106Cardiac Function
ShanghaiTech University
Not applicable
6
Shanghai
2024-10-10
Active, closed
Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis
NCT06615726Ischemic Stroke, Transient Ischemic Attack
Capital Medical University
Phase 3
1,300
Fuyang, Huainan, Suzhou, Wuhu, Beijing, Chongqing, Zhangzhou, Foshan
2024-10-10
Not yet open
A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy.
NCT06649448Solid Tumor Cancer, Chemotherapy Induced Neutropenia, G-CSF
Shandong Cancer Hospital and Institute
Not applicable
200
Jinan
2024-10-10
Recruiting
Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After Lumpectomy
NCT07135661Breast Cancer, Proton Therapy
Shanghai Proton and Heavy Ion Center
Not applicable
312
Shanghai
2024-10-10
Active, closed
3-Dimensional Mapping System: The PULSTAR II Study
NCT07586176Atrial Fibrillation (Paroxysmal), Paroxysmal AF, Pulsed Field Ablation
Shanghai Shangyang Medical Technology Co., Ltd.
Not applicable
152
Chengdu
2024-10-10
By invitation
Clinical Study on the Combination of Xiaoyu Zhitong Formula and Lymphatic Drainage Technique to Improve the Symptoms of Knee Pain and Swelling in Cold Dampness Obstruction Type
NCT06911437Knee Osteoarthritis (OA)
tang jie
Observational
100
Beijing
2024-10-10
Recruiting
A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
NCT06371274Triple-negative Breast Cancer
First Affiliated Hospital of Zhejiang University
Not applicable
29
Hangzhou
2024-10-10
Recruiting
Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis
NCT06418594HER2-negative Breast Cancer Brain Metastases
Beijing 302 Hospital
Phase 2
30
Beijing
2024-10-10
Recruiting
Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer
NCT06757621Breast Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
3,142
Beijing
2024-10-10
Recruiting
A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients
NCT06522828Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2
80
Chongqing
2024-10-10
Recruiting
Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell Carcinoma
NCT06690476Esophageal Squamous Cell Carcinoma
Peking University
Phase EARLY_PHASE1
74
Beijing
2024-10-10
Recruiting
A Randomized Crossover Study on Diverse Training Methods to Enhance University Athletes' Performance and Health
NCT06546605Athletic Performance, Plyometric Exercise, Healthy
University of Macau
Not applicable
120
2024-10-10
Recruiting
A Prospective, Single-arm Clinical Study on the Safety and Efficacy of Ivoximab Combined With Temozolomide in the Treatment of Relapsed/Refractory Glioma
NCT07599371Relapsed/Refractory Glioma
The First Affiliated Hospital of Zhengzhou University
Phase 1/2
29
Zhengzhou
2024-10-10
Recruiting
Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.
NCT06600022Advanced Malignant Solid Tumours
Sinocelltech Ltd.
Phase 1/2
441
Guangzhou
2024-10-10
Recruiting
ZR-MTX for PIOL Phase II Trial
NCT06973811Primary Intraocular Lymphoma
Peking Union Medical College Hospital
Phase 2
47
Beijing
2024-10-10
Recruiting
Coronary CT-Derived FFR-Guided Strategy Versus Medical Therapy
NCT05824520Coronary Artery Disease, Myocardial Ischaemia
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,066
Hangzhou
2024-10-10
Recruiting
Short-Term Nutritional Enhancement Combined With Health Education in Postoperative Colorectal Cancer Patients: A Randomized Controlled Trial
NCT07087561Colorectal Cancer (Diagnosis), Malnutrition or Risk of Malnutrition
Xiaoqin Luo
Not applicable
360
Xi'an
2024-10-10
Recruiting
The Effect of Repetitive Transcranial Magnetic Stimulation for Internet Gaming Disorder
NCT06634498Internet Gaming Disorder
Jin-tao Zhang
Not applicable
35
Zhenjiang, Beijing
2024-10-10
Recruiting
Virtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision
NCT06633133Rectal Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Not applicable
620
Chongqing
2024-10-10
Recruiting
A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus
NCT06535412Systemic Lupus Erythematosus
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
Phase 1/2
218
Beijing
2024-10-10
Recruiting
A Bioequivalence Study of PP3M in Patients With Schizophrenia
NCT07493551Schizophrenia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Not applicable
260
Beijing
2024-10-09
Recruiting
Study of LM-299 in Subjects Advanced Malignant Tumors
NCT06650566Malignant Tumors
LaNova Medicines Limited
Phase 1/2
108
Xinxiang, Liaocheng, Zibo, Shanghai
2024-10-09
Active, closed
Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)
NCT07236476Assisted Reproduction
Luye Pharma Group Ltd.
Phase 2
90
Beijing
2024-10-09
Not yet open
Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma
NCT06594211Multiple Myeloma
RenJi Hospital
Not applicable
18
Shanghai
2024-10-09
Recruiting
QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC
NCT06786026TNBC, Triple Negative Breast Cancer
Fudan University
Phase 2
60
Shanghai
2024-10-09
Recruiting
A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma
NCT06367075Advanced Soft-tissue Sarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
53
Wuhan
2024-10-09
Recruiting
Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy
NCT06590220Thyroid Associated Ophthalmopathy
Shanghai Changzheng Hospital
Observational
150
Shanghai
2024-10-09
By invitation
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects
NCT07057726Safety and Tolerability in Healthy Volunteers
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1
48
Beijing
2024-10-09
Active, closed
LuX-Valve Plus System for Severe or Greater Tricuspid Regurgitation
NCT07705594Tricuspid Regurgitation (TR)
Jenscare Scientific
Not applicable
126
Shanghai
2024-10-09
Active, closed
Neoadjuvant Short-Course Radiotherapy Followed by CAPOX Plus PD-1 Antibody and IL-2 in Locally Advanced Rectal Cancer (PRIDE01)
NCT06577194Rectal Cancer, Advanced Solid Tumor
The First Affiliated Hospital with Nanjing Medical University
Phase 2
35
Nanjing
2024-10-09
Recruiting
Efficacy Evaluation Study of BAT5906 and Lucentisยฎ in Patients With Diabetic Macular Edema
NCT07515079Diabetic Macular Edema (DME)
Bio-Thera Solutions
Phase 3
406
Beijing, Chongqing, Lanzhou, Guangzhou, Shantou, Shenzhen, Nanning, Zunyi
2024-10-09
Recruiting
JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
NCT06675422Systemic Lupus Erythematosus (SLE)
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Phase 1/2
20
Kunming
2024-10-09
Recruiting
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
NCT06470048Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals
Phase 2
200
Nanning, Zhengzhou, Changchun, Chengdu, Ningbo, Beijing, Tianjin
2024-10-09
Recruiting
Effects of Different Occlusion Angles of Disposable Tracheal Blocker on Right One-lung Ventilation
NCT06595043The Direction of Blocker Placement
China Medical University, China
Not applicable
96
Shenyang
2024-10-09
Recruiting
Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
NCT06682195TNBC, Triple Negative Breast Cancer
First Affiliated Hospital of Zhejiang University
Phase 2
35
Nanchang, Hangzhou, Harbin, Hefei, Jinhua, Nantong, Shanghai, Shanxi
2024-10-09
Recruiting
Smoking Cessation Program With CBT and Mindfulness Audio Support: A Randomized Controlled Trial
NCT06901713Smoking Cessation; Tobacco Dependence
Sir Run Run Shaw Hospital
Not applicable
2,000
Hangzhou
2024-10-09
Not yet open
The Safety and Efficacy of Multimodal Thermal Therapy in the Treatment of Early-stage Invasive Breast Cancer
NCT06635096Breast Cancer Female
Fudan University
Not applicable
60
Shanghai
2024-10-08
By invitation
CNCMT๏ผša Multi-center, Prospective, Single-arm Study
NCT06714084Locally Advanced Cervical Cancer, PD1, CTLA4
Hubei Cancer Hospital
Not applicable
20
Wuhan
2024-10-08
Recruiting
A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas
NCT06660056High-grade Gliomas
GONGCHU Biotechnology Co., Ltd
Phase 1
35
Beijing
2024-10-08
Recruiting
The Efficacy of Triple Regimen in Newly Diagnosed AML Patients With FLT3 Mutation
NCT06561880FLT3 Gene Mutation, AML
Institute of Hematology & Blood Diseases Hospital, China
Phase 1/2
66
Tianjin
2024-10-08
Active, closed
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
NCT06335979Systemic Lupus Erythematosus, SLE
Novartis Pharmaceuticals
Phase 1
54
Beijing
2024-10-08
Active, closed
Endocrine and Exocrine Secretory Function Alterations After Moderately Severe and Severe Acute Pancreatitis
NCT06590935Acute Pancreatitis (AP), Diabetes Mellitus
Shanghai Changzheng Hospital
Observational
120
Shanghai
2024-10-08
Recruiting
TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension
NCT06646198Hepatocellular Carcinoma with PVTT
Fei Gao
Phase 2
40
Guangzhou
2024-10-08
Recruiting
Effects of Different Pressure Garments on Upper Extremity Sensorimotor Functions and Quality of Life After Stroke
NCT06587308Cerebral Vascular Accident (CVA)/Stroke
National University of Malaysia
Not applicable
165
Weifang
2024-10-08
By invitation
The Effects and Mechanism of Parent Intervention for Autism Sprectrum Disorder
NCT07393893Autism Spectrum Disorder
University of Electronic Science and Technology of China
Not applicable
80
Chengdu
2024-10-08
Active, closed
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR + / HER2- Breast Cancer
NCT06599216Breast Cancer, HR+/HER2- Breast Cancer
Harbin Medical University
Phase 2
30
Harbin
2024-10-08
Recruiting
Efficacy and Safety of tACS for Depression: a Multicenter RCT Study
NCT06891326Depression Disorders
Ruijin Hospital
Not applicable
72
Shanghai
2024-10-08
Recruiting
Two Types of Single-use Flexible Ureteroscopies for the Treatment of Upper Urinary Tract Stones in Children
NCT06628765Urinary Stone
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
52
Hangzhou
2024-10-08
Active, closed
To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis
NCT06552520Atopic Dermatitis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 3
500
Bengbu, Tongling, Wuhu, Beijing, Chongqing, Xiamen, Guangzhou, Shenzhen
2024-10-08
Recruiting
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
NCT06612047Prostate Cancer
Anhui Provincial Hospital
Observational
150
Hefei
2024-10-08
Recruiting
Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome
NCT06602167Capecitabine, Hand-foot Syndrome, Electroacupuncture, Self-administered Acupressure
Affiliated Hospital of Qinghai University
Not applicable
220
Xining
2024-10-08
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression โ‰ฅ 1%
NCT06561386Non-small Cell Lung Cancer
Bristol-Myers Squibb
Phase 3
1,000
Hefei, Beijing, Chongqing, Wanzhou, Fuzhou, Guangzhou, Huizhou, Liuzhou
2024-10-07
Recruiting
AI-Assisted Non-Contrast CT for Multi-Cancer Screening
NCT06632886Lung Cancers, Liver Cancer, Gastric Cancers, Colorectal, Cancer
Guo ShiWei
Not applicable
1,000,000
Shanghai
2024-10-07
Recruiting
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
NCT06598306Extensive Stage Small Cell Lung Cancer
Amgen
Phase 1
220
Changchun, Shanghai
2024-10-07
Recruiting
Correlation Studies on Human Body Composition Based on Bioequivalence or Pharmacokinetic Trials
NCT07611929Healhty
Second Affiliated Hospital of Wenzhou Medical University
Observational
3,000
Wenzhou
2024-10-05
Recruiting
A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors
NCT06605222Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
201
Shanghai
2024-10-04
Recruiting
6-year Follow-up Data After the Berberine Intervention Trial
NCT06629051Colorectal Adenoma, Colorectal Cancer Control and Prevention, Colorectal Polyps
Shanghai Jiao Tong University School of Medicine
Observational
891
Shanghai
2024-10-04
Recruiting
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
NCT06644430Advanced Hepatocellular Carcinoma, Lung Cancer, Oligometastasis, Ablation
Sun Yat-sen University
Observational
470
Beijing
2024-10-04
Recruiting
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT06417814Metastatic Non-small Cell Lung Cancer
AstraZeneca
Phase 3
744
Baoding, Beijing, Bengbu, Changchun, Changsha, Chengdu, Deyang, Ganzhou
2024-10-04
Recruiting
ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer
NCT06825624Metastatic Colorectal Cancer (CRC)
Hansoh BioMedical R&D Company
Phase 1
560
Hangzhou
2024-10-03
Recruiting
A Study of BG-C477 in Participants With Advanced Solid Tumors
NCT06596473Advanced Solid Tumors
BeOne Medicines
Phase 1
310
Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Harbin, Jiamusi, Zhengzhou
2024-10-03
Recruiting
Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma
NCT07139509Relapsed/Refractory Multiple Myeloma(MM)
Xi'an No.3 Hospital
Phase 1
18
Xiโ€™an
2024-10-03
Recruiting
Extending the Time Window for Intravenous Tenecteplase in Patients With Distal Medium Vessel Occlusions Stroke
NCT06559436Acute Ischemic Stroke
The First Affiliated Hospital of University of Science and Technology of China
Not applicable
560
Hefei
2024-10-02
Recruiting
Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas
NCT06176027Relapsed Peripheral T-Cell Lymphomas, Refractory Peripheral T-Cell Lymphomas
Navy General Hospital, Beijing
Phase 1/2
52
Beijing
2024-10-01
Not yet open
Respiratory Disease Cohort Studies of Chinese Medicine for COPD(RESEARCH-COPD)
NCT06577701Chronic Obstructive Pulmoriary Disease (COPD), Preserved Ratio Impaired Spirometry (PRISM)
Henan University of Traditional Chinese Medicine
Observational
10,000
Zhengzhou
2024-10-01
Recruiting
Thumbtack Needle in the Treatment of NVP
NCT06566274Nausea and Vomiting in Pregnancy (NVP)
Dongmei Huang
Not applicable
320
Jingzhou, Nanzhang Chengguanzhen, Qianjiang, Shiyan, Suizhou, Wuhan, Xiangyang, Xiaogan
2024-10-01
Recruiting
Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors
NCT07492693Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors
Changhai Hospital
Phase 2
40
Shanghai
2024-10-01
Not yet open
Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI
NCT06441045Leptomeningeal Metastasis
Fujian Cancer Hospital
Phase 2
112
Fuzhou
2024-10-01
Recruiting
Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer
NCT07239063CRC (Colorectal Cancer), Lung Cancer (Diagnosis)
Nanfang Hospital, Southern Medical University
Observational
1,000
Guangzhou
2024-10-01
Recruiting
Multitarget Stereotactic Electrophysiological Recording and Stimulation for Tourette Syndrome
NCT06889480Tourette Syndrome, Deep Brain Stimulation
Beijing Tiantan Hospital
Not applicable
5
Beijing
2024-10-01
By invitation
Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis
NCT06999148Glioma (Any Grade) in the Brain
Yingjuan Zheng
Phase 2
216
Zhengzhou
2024-10-01
Not yet open
All-cause and Diseases-specific Mortality of High-risk HPV Infection
NCT06631495HPV Infection
Peking Union Medical College Hospital
Observational
100,000
Beijing
2024-10-01
Recruiting
TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
NCT06622031Hepatocellular Carcinoma, Portal Vein Tumor Thrombus, Systemic Therapy
Sun Yat-sen University
Not applicable
42
Beijing
2024-10-01
Recruiting
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
NCT06662071Bladder Cancer
Qilu Hospital of Shandong University
Observational
293
Binzhou, Dezhou, Jinan, Jining, Liaocheng, Linyi, Qingdao, Taian
2024-10-01
Recruiting
Tumor Regression Grade As Predictor of Adjuvant Therapy
NCT06710665Esophageal Squamous Cell Carcinoma (ESCC)
Fujian Medical University Union Hospital
Observational
400
Fuzhou
2024-10-01
Recruiting
PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC
NCT06742424Hepato Cellular Carcinoma (HCC)
West China Hospital
Phase 2
36
Chengdu
2024-10-01
Rows per page Showing 11201–11300 of 19052
Previous 111 112 113 114 115 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=113

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,786 of the 19,052 studies in this register are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3,920 have not yet opened recruitment, 2,668 are active but closed to new participants, and 678 are enrolling by invitation only. Eligibility for any study is decided by its study team.

→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.